As ADCs become more prevalent in cancer therapy, oncology nurses play a critical role in recognizing and managing the ocular ...

Experts from Lonza discuss how advances in ADCs, dual-payload designs, RNA delivery, and bioconjugates are expanding targeted ...

This article explores strategies for formulating complex and emerging biologics, the role of predictive modeling, and ...

For biopharma companies and CDMOs, the priority will shift from isolated digital bioprocess pilots toward building an ...

In a preview of their panel discussion at AAPS PharmSci 360 2026, Alfred Rumondor. PhD, AbbVie, and Swita Singh, PhD, Bristol ...

A national project set to develop brain-penetrating drugs that can overcome the biggest barrier in brain cancer treatment has received $18.8 million ...

IDEAYA Biosciences nears commercialization as darovasertib boosts PFS, supports NDA plans, and funds R&D to 2030. Learn more ...

In 2001, imatinib was the first proof that small molecule inhibitors targeting molecular drivers of cancer could be an ...

Formulation differentiates therapies in crowded markets by improving adherence, tolerability, convenience, and delivery efficiency.

A hydrogel converts chemical differences into spatial logic, using reaction boundaries to perform biological computing without cascaded molecular gates.

Evolving guidance and gaps in routine immunization present ongoing challenges for clinicians advocating for vaccine ...

AI’s Next Breakthrough Could Be Biomedical Discovery / AI in healthcare, AI-innovation, artificial intelligence, Biomedical ...